ROIV Roivant Sciences Ltd
- Stocks
- Healthcare
- NASDAQ: ROIV
Price (delayed)
$11.48
Market cap
$8.19B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.19
Enterprise value
$6.3B
Highlights
The company's quick ratio rose by 34% YoY
The company's gross margin rose by 4.4% YoY
The debt has surged by 90% since the previous quarter but it has dropped by 80% year-on-year
ROIV's gross profit is up by 49% YoY but it is down by 7% from the previous quarter
The net income has dropped by 105% year-on-year and by 105% since the previous quarter
The EPS has shrunk by 103% YoY and by 103% QoQ
Key stats
What are the main financial stats of ROIV
Market
Valuations
Earnings
Shares outstanding
713.55M
Market cap
$8.19B
Enterprise value
$6.3B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.61
Price to sales (P/S)
85.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
64.59
Revenue
$97.56M
Gross profit
$88.67M
Operating income
-$1B
Net income
-$219.23M
EBIT
-$208.07M
EBITDA
-$183.53M
Free cash flow
-$779.48M
Per share
Balance sheet
Liquidity
EPS
-$0.19
EPS diluted
-$0.19
Free cash flow per share
-$1.08
Book value per share
$7.13
Revenue per share
$0.13
TBVPS
$8.01
Total assets
$5.79B
Total liabilities
$256.38M
Debt
$100.31M
Equity
$5.19B
Working capital
$5.22B
Debt to equity
0.02
Current ratio
37.91
Quick ratio
36.38
Net debt/EBITDA
10.3
Margins
Efficiency
Dividend
EBITDA margin
-188.1%
Gross margin
90.9%
Net margin
-224.7%
Operating margin
-1,027.4%
Return on assets
-3.4%
Return on equity
-4%
Return on invested capital
-9.4%
Return on capital employed
-3.7%
Return on sales
-213.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ROIV stock price
How has the Roivant Sciences stock price performed over time
Intraday
-0.86%
1 week
4.27%
1 month
13.89%
1 year
2.14%
YTD
-2.96%
QTD
13.78%
Financial performance
How have Roivant Sciences's revenue and profit performed over time
Revenue
$97.56M
Gross profit
$88.67M
Operating income
-$1B
Net income
-$219.23M
Gross margin
90.9%
Net margin
-224.7%
ROIV's operating margin has dropped by 124% since the previous quarter and by 116% year-on-year
ROIV's operating income has dropped by 123% since the previous quarter and by 123% year-on-year
The net income has dropped by 105% year-on-year and by 105% since the previous quarter
The net margin has dropped by 105% since the previous quarter and by 103% year-on-year
Growth
What is Roivant Sciences's growth rate over time
Valuation
What is Roivant Sciences stock price valuation
P/E
N/A
P/B
1.61
P/S
85.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
64.59
The EPS has shrunk by 103% YoY and by 103% QoQ
The stock's price to book (P/B) is 83% less than its 5-year quarterly average of 9.2 but 7% more than its last 4 quarters average of 1.5
ROIV's equity is down by 15% year-on-year
Roivant Sciences's revenue has increased by 43% YoY but it has decreased by 6% QoQ
The stock's price to sales (P/S) is 23% less than its 5-year quarterly average of 111.0 but 9% more than its last 4 quarters average of 77.7
Efficiency
How efficient is Roivant Sciences business performance
The ROS has shrunk by 105% QoQ and by 103% YoY
ROIV's return on assets has dropped by 105% since the previous quarter and by 103% year-on-year
The ROE has shrunk by 105% QoQ and by 102% YoY
The ROIC has plunged by 103% from the previous quarter and by 102% YoY
Dividends
What is ROIV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ROIV.
Financial health
How did Roivant Sciences financials performed over time
ROIV's total liabilities has dropped by 65% year-on-year and by 59% since the previous quarter
Roivant Sciences's current ratio has increased by 36% YoY
The debt is 98% smaller than the equity
The debt to equity has surged by 100% since the previous quarter but it has dropped by 75% year-on-year
The debt has surged by 90% since the previous quarter but it has dropped by 80% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.